Found 10 matching trials
An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients PHASE2 This is an open-label extension study for patients who participated in the ...
Show More Location
Harbor-UCLA Medical Center
Learn More & Join Trial
Evaluation of Nail Fold Microcirculation in CKD PHASE4 To evaluation of nailfold microcirculation in patients with chronic renal f...
Show More Location
The Affiliated Hospital of Xuzhou Medical University
Learn More & Join Trial
Efficacy and Safety of Dorner Tablets and Aspirin for Prevention of Arteriosclerosis Progress in Type 2 Diabetes Mellitus Patients PHASE4 The objective was to evaluate the efficacy and safety of combination of ber...
Show More Learn More & Join Trial
Protective Effect of Beraprost Sodium Tablets on Reperfusion Therapy for Acute STEMI EARLY_PHASE1 Protective effect of Beraprost Sodium Tablets on coronary microcirculation ...
Show More Location
Shenzhen People' S Hospital
Learn More & Join Trial
A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension PHASE3 This is a multi-center, open-label study for eligible participants who were...
Show More Location
The University of Alabama at Birmingham
Learn More & Join Trial
Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients PHASE2 This is an open-label study for patients who participated in the BPS-MR-PAH...
Show More Location
Harbor-UCLA Medical Center
Learn More & Join Trial
Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH) PHASE2 This is a 12-week, international, multicenter, double-blind, three-group, d...
Show More Location
Harbor-UCLA Medical Center
Learn More & Join Trial
A Multinational, Multicenter, Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonary Arterial Hypertension Currently Receiving Treatment With an Endothelin Receptor Antagonist and/or a Phosphodiesterase-5 Inhibitor PHASE3 A multinational, multicenter, double-blind, randomized, placebo-controlled,...
Show More Location
Multiple Locations
Learn More & Join Trial
A Multi-Center, Open-Label, Multiple Dose, Dose Finding Study Exploring the Safety and Tolerability of Beraprost Sodium Modified Release in PAH Patients PHASE2 This study is an international, open-label, multi-center, Phase II, multipl...
Show More Location
Harbor-UCLA Medical Center
Learn More & Join Trial
Beraprost-314d Added-on to Tyvaso® (BEAT) PHASE3 This is a multicenter, double-blind, randomized, placebo-controlled Phase 3...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial